Distinct chromatin functional states correlate with HIV latency reactivation in infected primary CD4+ T Cells
Abstract
Human immunodeficiency virus (HIV) infection is currently incurable, due to the persistence of latently infected cells. The 'shock and kill' approach to a cure proposes to eliminate this reservoir via transcriptional activation of latent proviruses, enabling direct or indirect killing of infected cells. Currently available latency-reversing agents (LRAs) have however proven ineffective. To understand why, we used a novel HIV reporter strain in primary CD4+ T cells and determined which latently infected cells are reactivatable by current candidate LRAs. Remarkably, none of these agents reactivated more than 5% of cells carrying a latent provirus. Sequencing analysis of reactivatable vs.non-reactivatable populations revealed that the integration sites were distinguishable in terms of chromatin functional states. Our findings challenge the feasibility of 'shock and kill', and suggest the need to explore other strategies to control the latent HIV reservoir.
Data availability
All sequencing data generated during this study are included in the Integration sites Source data file 1
Article and author information
Author details
Funding
Center for AIDS Research, University of California, San Francisco and Gladstone Institute of Virology and Immunology
- Emilie Battivelli
- Mohamed Abdel-Mohsen
National Institute of Dental and Craniofacial Research (5-31532)
- Eric Verdin
California HIV/AIDS Research Program
- Emilie Battivelli
Canadian Institutes of Health Research (201311MFE-321128-179658)
- Matthew S Dahabieh
Svenska Forskningsrådet Formas (VR2015-02312)
- J Peter Svensson
National Institute of Allergy and Infectious Diseases (R01Ai117864)
- Eric Verdin
National Institute on Drug Abuse (1R01DA041742-01)
- Eric Verdin
National Institute of Dental and Craniofacial Research (1R01DE026010-01)
- Eric Verdin
National Institute of Allergy and Infectious Diseases (R21AI129636)
- Mohamed Abdel-Mohsen
Cancerfonden (CAN2016/576)
- J Peter Svensson
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Copyright
© 2018, Battivelli et al.
This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 6,119
- views
-
- 1,166
- downloads
-
- 133
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Further reading
-
- Biochemistry and Chemical Biology
- Microbiology and Infectious Disease
Birnaviruses are a group of double-stranded RNA (dsRNA) viruses infecting birds, fish, and insects. Early endosomes (EE) constitute the platform for viral replication. Here, we study the mechanism of birnaviral targeting of EE membranes. Using the Infectious Bursal Disease Virus (IBDV) as a model, we validate that the viral protein 3 (VP3) binds to phosphatidylinositol-3-phosphate (PI3P) present in EE membranes. We identify the domain of VP3 involved in PI3P-binding, named P2 and localized in the core of VP3, and establish the critical role of the arginine at position 200 (R200), conserved among all known birnaviruses. Mutating R200 abolishes viral replication. Moreover, we propose a two-stage modular mechanism for VP3 association with EE. Firstly, the carboxy-terminal region of VP3 adsorbs on the membrane, and then the VP3 core reinforces the membrane engagement by specifically binding PI3P through its P2 domain, additionally promoting PI3P accumulation.
-
- Biochemistry and Chemical Biology
- Microbiology and Infectious Disease
In the bacterium M. smegmatis, an enzyme called MftG allows the cofactor mycofactocin to transfer electrons released during ethanol metabolism to the electron transport chain.